Recent advancements in technology are enabling automation to help address the growing PV challenges organizations face. Yet, when webinar attendees were asked “Does your company have a strategic plan for PV Automation?” responses were mixed.

What is the greatest challenge across end-to-end pharma processes? How would you rate your automation capabilities? This two-part blog series analyzes attendee polling responses from a recent DIA webinar and shares ArisGlobal’s thinking about practical use cases for automation in pharmacovigilance and regulatory.

This is the second in a three-part blog series on National Pharmacovigilance systems and the role of technology in bridging the gaps in pharmacovigilance of regulatory authorities around the world.